Nectar Lifesciences

NECLIFE

Price
Micro Cap
₹512 Cr.
Nectar Lifesciences (NLL) is a knowledge driven organization which constitutes a vital part of fast growing Indian Pharmaceutical Industry. NLL has transformed itself from being a small Domestic API player to one of the most integrated player in the Global Cephalosporins Industry within Anti Infective Therapeutic segment. NLL is catapulting itself into Ceph… More
Nectar Lifesciences (NLL) is a knowledge driven organization which constitutes a vital part of fast growing Indian Pharmaceutical Industry. NLL has transformed itself from being a small Domestic API player to one of the most integrated player in the Global Cephalosporins Industry within Anti Infective Therapeutic segment. NLL is catapulting itself into Cephalosporin Formulations in a defining way by entering lucrative regulated markets like US & European Union. Less
Nectar Lifesciences (NLL) is a knowledge driven organization which constitutes a vital part of fast… More
Nectar Lifesciences (NLL) is a knowledge driven organization which constitutes a vital part of fast growing Indian Pharmaceutical Industry. NLL has transformed itself from being a small Domestic API player to one of the most integrated player in the Global Cephalosporins Industry within Anti Infective Therapeutic segment. NLL is catapulting itself into Cephalosporin Formulations in a defining way by entering lucrative regulated markets like US & European Union. Less
Low
20.99
52W Range
High
56.50
PE
30.13
Sector PE
25.8
P/B
0.48
Div.Yield
--
ROE
0.47%
EBIDTA
6.37
ROCE
9.51
EPS
0.35

Recent events

  • News

  • Corporate Actions

India's Nectar Lifesciences falls after European agencies flag concerns at facility

Mar 11, 2025

Nectar Lifesciences Says API Manufacturing Facility, Punjab Undergone Joint Inspection By EDQM, AEMPS

Mar 10, 2025

Nectar Lifesciences Receives Tax Relief Of 35.8 Mln Rupees

Jan 20, 2025

Nectar Lifesciences Says Investment Agreement With Isengard Direct PE LLC Stands Terminated

Dec 13, 2024

Nectar Lifesciences Sept-Quarter Consol Profit From Continuing Operations 56 Million Rupees

Nov 14, 2024

Nectar Lifesciences June-Quarter Consol Profit From Cont Ops 29.7 Million Rupees

Aug 14, 2024

Nectar Lifesciences March-Quarter Consol Profit From Continuing Operations Falls

May 15, 2024

Nectar Lifesciences Reports Profit For Dec-Qtr

Feb 14, 2024

India's Nectar Lifesciences June-Quarter Consol Profit From Cont Ops Falls

Aug 14, 2023

India's Nectar Life Sciences March-Quarter Consol Profit From Continuing Operations Falls

May 26, 2023

Events:

Announcement Date
Jan 31, 2025
Announcement Date
Nov 14, 2024
Announcement Date
Aug 14, 2024
Announcement Date
Aug 14, 2024
Announcement Date
Feb 14, 2024
Announcement Date
Nov 10, 2023
Announcement Date
Aug 14, 2023
Announcement Date
Aug 14, 2023
Announcement Date
May 26, 2023
Announcement Date
Feb 14, 2023
Announcement Date
Nov 14, 2022
Announcement Date
Aug 24, 2022
Announcement Date
Aug 13, 2022
Announcement Date
May 30, 2022
Announcement Date
Feb 14, 2022
Announcement Date
Nov 13, 2021
Announcement Date
Aug 14, 2021
Announcement Date
Jul 23, 2021
Announcement Date
Feb 13, 2021
Announcement Date
Oct 30, 2020
Announcement Date
Sep 14, 2020

Dividend

Dividend of Rs.0.05 per share
Ex Date
Sep 11, 2020
Announcement Date
Jul 29, 2020
Announcement Date
Feb 11, 2020

Dividend

Dividend of Rs.0.05 per share
Ex Date
Sep 19, 2019

Dividend

Dividend of Rs.0.05 per share
Ex Date
Sep 19, 2018

Dividend

Dividend of Rs.0.05 per share
Ex Date
Sep 20, 2017

Dividend

Dividend of Rs.0.1 per share
Ex Date
Sep 22, 2016

Dividend

Dividend of Rs.0.1 per share
Ex Date
Sep 22, 2015

Dividend

Dividend of Rs.0.1 per share
Ex Date
Aug 21, 2014

More Micro Cap Ideas

See similar 'Micro' cap companies with recent activity

Promoter Buying

Companies where the promoters are bullish

Capex

Companies investing on expansion

Superstar Investor

Companies where well known investors have invested